Central line remnants after removal in ICU patients
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at what happens to a small part of the central line (called CRT) that sometimes stays in the vein after the tube is removed. It uses ultrasound to check the vein and is for patients in the intensive care unit (ICU) who are having their central line taken out.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You are currently staying in an intensive care unit (ICU) in a hospital.
- You have a central line (a long IV tube placed in a large vein near the heart) that is scheduled to be removed.
- You are willing to take part in the study and sign a consent form.
- You do not have any skin problems in the area that would make it impossible to do an ultrasound exam.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special CT scans (photon-counting CT) to look for blood clots related to central lines, both in patients who have passed away and in living patients. It aims to better understand and detect these clots.
This trial tests a new way to place a central line (a tube in a large vein) using ultrasound and a special ECG technique to improve accuracy. It may help people in intensive care who need this procedure.
This study looks at how often people with a blood infection from a PICC or midline catheter also get a blood clot in the vein of their arm. The goal is to learn more about this problem so doctors can better prevent and treat it.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This study follows people with a blood clot in the calf vein to learn how the clot changes over time using repeat ultrasound scans. It may help doctors understand who needs treatment and who can be watched safely.
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
Hear when a new Post Thrombotic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.